Piera Maiolino

1.7k citations
47 papers · 915 indexed · h-index 17
Topics
Cancer Immunotherapy and Biomarkers (8 papers)Immunotherapy and Immune Responses (7 papers)Immune Cell Function and Interaction (6 papers)

In The Last Decade

Piera Maiolino

45 papers receiving 902 citations

Peers

Piera Maiolino
Comparison fields: 5 of 91
  • Oncology 452
  • Immunology 409
  • Molecular Biology 244
  • Physiology 219
  • Pulmonary and Respiratory Medicine 104
Replace Masahisa Handa with:
Masahisa Handa United States
Lucio Morabito Italy
Roberta Angioni Italy
Inés Santisteban United States
Manik Amin United States
Katsuhiro Yoshimura Japan
Marissa Rybstein United States
Kai Yin China
Yibing Bai China
Hao‐Chen Wang Taiwan
Piera Maiolino relative to Masahisa Handa United States Masahisa Handa's profile →
Citations per field
00.5×11.4×
Masahisa Handa · 1×
Citations per year

Countries citing papers authored by Piera Maiolino

Since Specialization
Citations

This map shows the geographic impact of Piera Maiolino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piera Maiolino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piera Maiolino more than expected).

Fields of papers citing papers by Piera Maiolino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piera Maiolino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piera Maiolino. The network helps show where Piera Maiolino may publish in the future.

Co-authorship network of co-authors of Piera Maiolino

This figure shows the co-authorship network connecting the top 25 collaborators of Piera Maiolino. A scholar is included among the top collaborators of Piera Maiolino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piera Maiolino. Piera Maiolino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 14
3 2
4 19
5 5
6 10
7 12
8 8
9 81
10 3
11 2
12 3
13 15
14 19
15 20
16 123
17 61
18 23
19 14
20 9

About Piera Maiolino

Piera Maiolino is a scholar working on Physiology, Oncology and Immunology, having authored 47 papers that have together received 915 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Physiology (219 citations), Immunology (409 citations) and Oncology (452 citations). Piera Maiolino has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Aldo Pinto, Silvana Morello, Raffaella Iannone, Lucio Miele, Claudio Arra, Antonio Luciano, Rosalinda Sorrentino, Ian M. Adcock, Antonella Montinaro and Giovanni Forte. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026